The mycobacterial bacillus is encompassed by a remarkably elaborate cell wall structure. The mycolyl-arabinogalactan-peptidoglycan (mAGP) complex is essential for the viability of Mycobacterium tuberculosis and maintains a robust basal structure supporting the upper "myco-membrane." M. tuberculosis peptidoglycan, although appearing to be unexceptional at first glance, contains a number of unique molecular subtleties that become particularly important as the TB-bacilli enters into nonreplicative growth during dormancy. Arabinogalactan, a highly branched polysaccharide, serves to connect peptidoglycan with the outer mycolic acid layer, and a variety of unique glycolsyltransferases are used for its assembly. In this review, we shall explore the microbial chemistry of this unique heteropolysacchride, examine the molecular genetics that underpins its fabrication, and discuss how the essential biosynthetic process might be exploited for the development of future anti-TB chemotherapies.
THE MYCOBACTERIAL CELL WALL-PEPTIDOGLYCAN AND ARABINOGALACTAN
T he remarkable molecular complexity of the mycobacterial cell wall is a particularly distinguishing feature that set Mycobacterium species apart from the majority of other prokaryotes. Although classified as gram-positive organisms, their envelopes do in fact share notable features with Gram-negative cell walls, such as an outer permeability barrier acting as a pseudo-outer membrane (Minnikin 1982; Brennan and Nikaido 1995) . Much of the early structural definition of the cell wall was conducted in the 1960s and 1970s Petit et al. 1969 ; Lederer et al. 1975) and later continued by Minnikin, who in 1982 proposed the currently accepted structural model for the cell wall architecture (Minnikin 1982) . The mycolyl-arabinogalactan-peptidoglycan (mAGP) complex, as it is commonly termed, represents the cell wall core structure that encompasses the mycobacterial bacilli.
2001). Its mesh-like arrangement confers rigidity to the cell, allowing it to withstand osmotic pressure maintaining cell integrity and cellular shape. Relatively little is known about Mycobacterium tuberculosis PG synthesis, although it is generally assumed to be analogous to that of Escherichia coli (van Heijenoort 2001), also being classified as A1g according to the classification system of Schleifer and Kandler (1972) . Mycobacterial PG forms the basal layer of the mAGP complex and is composed of alternating N-acetylglucosamine (GlcNAc) and modified muramic acid (Mur) residues, linked in a b(1 ! 4) configuration (Lederer et al. 1975) . Unlike E. coli PG, the muramic acid residues in both M. tuberculosis and Mycobacterium smegmatis contain a mixture of N-acetyl and N-glycolyl derivatives, whereby the N-acetyl function has been oxidized to a N-glycolyl function to form MurNGly (Mahapatra et al. 2000 Raymond et al. 2005) . Although the precise function of the N-glycolyl modifications is yet to be elucidated, it has been hypothesized that these additional glycolyl-containing residues might have the potential for additional hydrogen bonding interactions, strengthening the mesh-like structure of the PG layer (Brennan and Nikaido 1995) , as well as possibly protecting the organism from degradation via lysozyme (Chatterjee et al. 1991) . Tetrapeptide side chains consisting of L-alaninyl-D-isoglutaminylmeso-diaminopimelyl-D-alanine are crosslinked with identical short peptides of neighboring glycan chains . These cross-links include the expected 3 ! 4 mesodiaminopimelic acid (DAP) and D-alanine bond that is common to most prokaryotes, but also a high degree of 3 ! 3 bonds between two residues of DAP (Ghuysen 1968; Wietzerbin-Falszpan et al. 1970) . The proportion of cross-linking in Mycobacterium species is 70% -80% (Matsuhashi 1966) , significantly more so than E. coli, with only 50% (Vollmer and Holtje 2004 ). An additional deviation from E. coli PG is the use of the muramic acid residues as attachment sites for the galactan domain of the arabinogalactan, whereby 6-OH of some of the muramic acid residues form a phosphodiester bond and are linked to the a-L-rhamnopyranose -(1 ! 3)-a-D-GlcNAc (1 ! P) linker unit of AG .
One model proposed for the three-dimensional topology of the mAGP complex, consistent with the traditional models of PG architecture (Ghuysen 1968; Brennan and Nikaido 1995) , suggests that the PG and the galactan moiety run parallel to the plasma membrane. However, an opposing model put forward by other modeling studies predicts that the PG and the AG polymers may in fact be coiled and are thus orientated perpendicular to the plane of the plasma membrane (Dmitriev et al. 2000 (Dmitriev et al. , 2003 . Minnikin et al. (2002) proposed that both AG and LAM polymers form coiled strands and integrate with the basal PG layer. Interestingly, a study by Meroueh et al. (2006) presented compelling evidence in the form of nuclear magnetic resonance (NMR) data that suggests that the PG glycan strand is orthogonal to the plane of the membrane; thus, the overall three-dimensional structure and topology remain open to debate.
Biosynthesis of Mycobacterial Peptidoglycan

Cytoplasmic Steps of Peptidoglycan Intermediate Metabolism
The biosynthesis of PG begins within the cytoplasm of all bacteria that contain a murein sacculus, and the activated sugar nucleotide UDPGlcNAc is usually considered to be the "start point" of PG anabolism. UDP-GlcNAc is synthesized from D-fructose-6-phosphate in four steps and requires three enzymes. GlmS is an aminotransferase that converts D-fructose-6-phosphate to D-glucosamine-1-phosphate, and although a clear ortholog is present in M. tuberculosis, there has been no investigation of this gene or protein to date (Durand et al. 2008) . GlmM is a mutase enzyme that converts Dglucosamine-1-phosphate to D-glucosamine-6-phosphate and has been shown to be an essential gene in M. smegmatis (Li et al. 2012) . Indeed, the conversion of D-glucosamine-6-phosphate to Dglucosamine-1-phosphate is unique to prokaryotes and is considered a potential drug target (Li et al. 2011) . GlmU is a bifunctional enzyme that carries out both acetylation and uridylation reactions, ultimately forming UDP-GlcNAc (Jagtap et al. 2012 (Jagtap et al. , 2013 . The carboxy-terminal domain of GluU is responsible for catalyzing acylation of D-glucosamine-6-phosphate whereas the amino-terminal domain catalyzes uridylation of N-acetylglucosamine-1-phosphate. GlmU has been shown to be an essential gene in M. smegmatis (Zhang et al. 2008) . Interestingly, a single threonine residue within the carboxyterminal domain of GlmU is phosphorylated by the serine/threonine protein kinase PknB, resulting in a modulation of GlmU acetyltransferase activity (Parikh et al. 2009 ).
UDP-MurNAc is formed from UDPGlcNAc in a two-step process involving the catalytic activities of two enzymes, MurA and MurB. MurA is a UDP-GlcNAc enolpyruvyl transferase that catalyzes the transfer of enolpyruvate from phosphoenoylpyruvate to the 3-position of the N-acetylglucosamine moiety of UDP-GlcNAc, liberating inorganic phosphate in the process. Fosfomycin is an analog of phosphoenoylpyruvate and it inhibits MurA by alkylating an active site cysteine residue (Kim et al. 1996) . However, although fosfomycin is considered to be a broad-spectrum antibiotic, it has no ready utility as an antitubercular drug. M. tuberculosis is inherently resistant to fosfomycin because of the presence of an aspartic acid in place of the aforementioned cysteine, which usually confers sensitivity to the drug (De Smet et al. 1999) . MurB is a reductase that uses NADPH as an electron donor to convert the enolpyruvate moiety to D-lactoyl, thus delivering UDP-MurNAc as a final product. To date, the investigation of MurB from mycobacteria has been limited to in silico homology modeling and molecular dynamics simulations (Kumar et al. 2011) .
The intracellular ATP-dependent muramic acid ligase enzymes, MurC -MurF, work consecutively to synthesize UDP-N-acetylmuramyl pentapeptide and UDP-N-glycolylmuramyl pentapeptide from either UDP-MurNAc or UDPMurNGlyc, respectively. M. tuberculosis UDPMurNGlyc is initially generated by hydroxylation of the methyl group of the MurNAc moiety of UDP-MurNAc (Gateau et al. 1976; Essers and Schoop 1978) . Conversion of UDP-MurNAc to UDP-MurNGlyc involves a monooxygenase encoded by the namH gene (Raymond et al. 2005) . Chemical analysis of the nucleotidelinked PG intermediates from M. tuberculosis strongly suggests that this pool of metabolites is composed of a mixture of both MurNAc and MurNGlyc subtypes, in which the proportion of MurNAc precursors is heavily suppressed by the presence of D-cycloserine but not vancomycin . The UDP-MurNGlyc and UDP-MurNAc intermediates are then perpetuated throughout the PG pathway by the successive additions of Lalanine (MurC), D-glutamate (MurD), meso-DAP (MurE), and D-alanyl-D-alanine (MurF), a unique prokaryotic pathway, which has been extensively reviewed by other investigators (Barreteau et al. 2008) . The Mur ligases C-F share a common mechanism whereby the carboxyl group appended to the UDP substrate is activated by phosphorylation with ATP, generating ADP. The UDP-substrate phospho-intermediate is then attacked by an amino acid or dipeptide specific to the ligase catalyzing the reaction, resulting in extension by aminoacylation of the UDP precursor and the expulsion of inorganic phosphate (Falk et al. 1996; Bouhss et al. 1999 ). Both M. tuberculosis and Mycobacterium leprae MurC orthologs have been shown to be capable of ligating both L-alanine and L-glycine to UDPMurNAc (Mahapatra et al. 2000) . Apart from MurC, the only other ATP-dependent Mur ligase that has been biochemically characterized is MurE (Basavannacharya et al. 2010a,b) .
Several other enzymes play vital roles in the cytoplasmic assembly of PG, two of which are the Alr and Ddl proteins that provide L-alanine racemase activity and D-alanine:D-alanine ligase activity, respectively (Feng and Barletta 2003) . Several recent biochemical studies have provided comprehensive molecular insight into how D-cycloserine (currently used as a secondline anti-TB agent) inhibits the Ddl enzyme (Prosser and de Carvalho 2013a,b) . In this regard, a number of high-throughput screening studies have identified Alr as being an equally interesting drug target (Anthony et al. 2011; Lee et al. 2013) .
Polyprenyl phosphates play a crucial role in prokaryotic cell wall biosynthesis, providing a hydrophobic lipid anchor that enables cell envelope biosynthesis to occur while being tethered to the cytoplasmic membrane. In mycobacteria, MurX (usually termed MraY in other prokaryotes) is an integral membrane protein that transfers the phospho-MurNAc-pentapeptide to a decaprenol phosphate lipid. The result is the displacement of the UDP nucleotide moiety with a decaprenyl lipid carrier, thus forming lipid I from Park's nucleotide. Although the molecular genetics or biochemistry of MurX has not been studied in detail, it appears that MurX from M. smegmatis is capable of incorporating the muramyl-pentapeptide from both UDP-N-acetylmuramyl pentapeptide and UDP-N-glycolylmuramyl pentapeptide precursors with equal efficiency (Chen et al. 2013) . MurG is a GT-B glycosyltransferase that uses UDP-GlcNAc as a substrate to form a b(1 ! 4) glycosidic bond between GlcNAc and either the MurNAc or MurNGlyc sugar of lipid I. MurG from M. tuberculosis has been shown to be able to complement a murG-deficient strain of E. coli (Jha et al. 2012) , and because of the essential nature of MurG, it is a target for the development of new antibacterial agents (Trunkfield et al. 2010) . MurG marks the final "step" in the cytoplasmic pathway of PG biosynthesis, and its product is a cell wall intermediate termed lipid II.
The Latter Stages of Peptidoglycan Assembly
The cytoplasmic membrane presents a physical barrier that separates the cytoplasm from the outer periplasmic space of the mycobacterial cell, as well as a thermodynamic hurdle that must be overcome by numerous cell wall intermediates that are destined for deposition in the mycobacterial envelope. Lipid II separates the cytoplasm from the outer periplasmic space of the mycobacterial cell. Several biochemical and molecular genetic investigations in other nonmycobacterial prokaryotes have identified both MurJ and FtsW proteins as being candidate proteins that translocate lipid II across the bacterial cytoplasmic membrane (Ruiz 2008; Mohammadi et al. 2011; Butler et al. 2013; Mohamed and Valvano 2014) . FtsW belongs to the shape, elongation, division, and sporulation (SEDS) family of proteins, all of which are integral membrane proteins involved in translocation of molecules across the cytoplasmic membrane. Interestingly, RodA is also a member of the SEDS family, and a recent study has shown that this protein also contributes lipid II flippase activity as well as having a direct interaction with the polar growth organizing protein, DivIVA (Sieger et al. 2013) .
Two proteins, PonA1 and PonA2, encoded by Rv0050 and Rv3682, respectively, are bifunctional penicillin-binding proteins that carry out both transglycoylase and transpeptidase enzymatic reactions, both of which use lipid II as a substrate. Studies on PonA1 from M. smegmatis have shown that apart from it being necessary for maintaining cell shape, viability, and integrity, this enzyme is also required for synergistic regulation of PG hydrolysis by interacting with the RipA-RpfB complex, a lytic transglycosylase and endopeptidase, respectively (Hett et al. 2010 ). PonA2 has also been attributed to having an important role in maintaining cell shape, integrity, and adaptation of M. tuberculosis into dormancy (Patru and Pavelka 2010) . However, a recent biochemical and structural study of the PASTA domain from PonA2 has shown that this protein is unable to bind classical cognate ligands, such as muropeptides, b-lactams, or nascent PG (Calvanese et al. 2014) .
PBPa and PBPb are two variants of the high-molecular-mass penicillin-binding proteins found in M. tuberculosis. PBPa is a class A penicillin-binding protein that plays an important role in the cell division process and maintenance of cell shape (Dasgupta et al. 2006 ). PknB, a serine/threonine-specific protein kinase, has been shown to phosphorylate PBPa on two key threonine residues T362 and T437, the latter of which is crucial to enable full signal transduction -mediated control of this important cell wall process (Dasgupta et al. 2006 ). Interestingly, both PBPa and PBPb have been shown to directly interact with the cell division L.J. Alderwick et al. complex and septal formation machinery FtsZ, FtsQ, and CrgA (Plocinski et al. 2011) .
Although the PG of actively replicating M. tuberculosis contains a network of classical 3 ! 4 transpeptide bonds, PG from nonreplicating M. tuberculosis contains significantly more nonclassical 3 ! 3 linkages. Thus, a significant molecular rearrangement must occur in the PG of M. tuberculosis as its shifts its mode of growth from one of propagation into one of dormancy. The M. tuberculosis genome encodes at least five nonclassical L,D-transpeptidases (Ldt), which are the enzymes responsible for generating 3 ! 3 linkages between opposing stem peptides in mycobacterial PG. M. tuberculosis deficient in both LdtMt1 and LdtMt2 activities shows an altered cell surface morphology and severely attenuates the growth and virulence of M. tuberculosis (Schoonmaker et al. 2014) . Other biochemical studies have identified LdtM2 as being important for resistance to blactam antibiotics such as amoxicillin (Gupta et al. 2010 ) as well as carbapenems, and the structural basis for the inhibition of LdtMt2 by meropenem has been elucidated Li et al. 2013 ). The X-ray crystal structure of LdtMt1 has also been solved in the apo and meropenem-bound form, highlighting some subtle differences between these two variants of L,D-transpeptidases (Correale et al. 2013 ).
ARABINOGALACTAN Structural Features of Arabinogalactan
Arabinogalactan (AG) is a heteropolysaccharide that is covalently tethered to 10%-12% of the muramic acid residues of PG via a phosphodiester bond (Amar and Vilkas 1973) . Collectively, PG and AG form a huge macro polymer positioned between the cytoplasmic membrane and the outer mycolic acid layer of the TB bacilli. Early work showed that AG was composed predominantly of arabinose and galactose and constitutes 35% of the total mass of the cell envelope (Misaki and Yukawa 1966; Azuma et al. 1968; Kanetsuna 1968; Kanetsuna et al. 1969) . Both arabinose and galactose sugars are present in the furanoid ring form, D-galactofuranosyl (Galf ) and D-arabinofuranosyl (Araf ), which appear infrequently in nature (McNeil et al. 1987) . A comprehensive characterization of oligomers generated from partial depolymerization of per-O-alkylated AG using gas chromatography -mass spectrometry (GC-MS), fast-atom bombardment -mass spectrometry (FAB-MS), and NMR spectroscopy resolved the detailed structure of the AG complex (McNeil et al. 1987; Daffé et al. 1990; McNeil et al. 1994; Besra et al. 1995) . The molecular structure of AG can be segmented into three separate constituents: the linker unit (LU), galactan, and arabinan. Amar and Vilkas (1973) initially reported that AG is tethered to PG at intervals by a phosphodiester bond, supported by the presence of muramyl-6-phosphate in cell wall preparations from several mycobacterial species (Liu and Gotschlich 1967; Kanetsuna 1968) . The chemical nature of this link was not answered until 20 years later when oligosaccharides containing Galf from the galactan domain were isolated along with rhamnose (Rha) residues ). The further discovery of the disaccharide L-Rhap-(1 ! 3)-DGlcNAc led to the conclusion that these constituents make up the linkage unit and the inference that the GlcNAc is directly attached to the 6-position of a proportion of the muramyl residues of PG ). The D-galactan component of AG is composed of approximately 30 linear alternating b(1 ! 5) and b(1 ! 6) Galf residues (Amar and Vilkas et al. 1973; McNeil et al. 1987) and is attached to the rhamnosyl residue of the LU. Three tricosamer domains of D-arabinan, each composed of approximately 23 Araf residues, are affixed to the C-5 hydroxyl of b(1 ! 6)-linked Galf units (Besra et al. 1995) specifically to the 8th, 10th, and 12th Galf residues of the galactan domain (Alderwick et al. 2005) . The arabinan domain is a highly branched polysaccharide built on a backbone of a(1 ! 5)-linked sugars with a number of a(1 ! 3)-linked residues forming 3,5-Araf branchpoints (Daffé et al. 1990 ). Further a(1 ! 5)-linked Araf sugars are attached subsequent to this branchpoint with the nonreducing ends terminated by b(1 ! 2) Araf residues. The final structural motif (Araf-b(1 ! 2)-Araf-a(1-) 2 ! 3,5-Araf-a(1 ! 5)-Araf-a(1!)) is a distinctive hexa-arabinoside (Ara 6 ) of which approximately two-thirds are esterified with mycolic acids . AG from M. tuberculosis is also further decorated with succinyl residues and galactosamine (GalN) located on the 2-position of an inner 3,5-a-D-Araf bifurcation point of approximately one-third of the arabinan tricosamers (Draper et al. 1997; Lee et al. 2006; Bhamidi et al. 2008; Peng et al. 2012) . The last two decades has witnessed a dramatic increase in our understanding of how this complex polymer is assembled. Much emphasis has been placed on investigating the molecular genetics of how this complex structure is assembled in mycobacteria. The complete sequencing of several genomes from mycobacteria and other closely related species has provided major impetus in the identification and the study of the enzymes involved in the biosynthesis of this exceptional structure, with the hope of uncovering new drug targets.
Biosynthesis of Arabinogalactan
Biosynthesis of the Linker Unit
The crucial structural role of the LU in the attachment of AG to PG, as well as the presence of L-rhamnose, a sugar absent in humans, makes the biosynthetic pathway leading to the formation of this disaccharide an attractive drug target ). In M. tuberculosis, LU biosynthesis is initiated on the isoprenoid lipid carrier decaprenyl-phosphate (C 50 -P), whereby GlcNAc-phosphate is transferred from the activated sugar donor UDP-GlcNAc, thus forming C 50 -P-P-GlcNAc, referred to as glycolipid 1 (GL-1) (Mikusova et al. 1996) . Rv1302 shows a high degree of homology with the WecA protein from E. coli (Amer and Valvano 2002; Lehrer et al. 2007 ). Recent biochemical characterization of this enzyme shows that Rv1302 is indeed a decaprenyl-phosphate a-N-acetylglucosaminyltransferase responsible for the formation of GL-1 (Ishizaki et al. 2013) , and the gene encoding WecA is essential for growth in M. smegmatis (Jin et al. 2010 ). The LU is completed by the subsequent action of the rhamnosyltransferase WbbL, which adds an L-Rhap to the 3-position of the GlcNAc of GL-1, this forming glycolipid 2 (GL-2) (Mills et al. 2004) . WbbL uses the highenergy nucleotide sugar donor dTDP-rhamnose as a substrate for the formation of GL-2. Because formation of GL-2 is an essential biosynthetic step (Mills et al. 2004) , the biosynthetic pathway leading to the formation dTDP-rhamnose has been heavily investigated, and a number of inhibitors of this process have been reported Babaoglu et al. 2003; Kantardjieff et al. 2004 ). Synthesis of dTDP-Rha occurs via a linear 4-stage pathway using the gene products of rmlABCD. RmlA (Rv0334) sets in motion the sequence of reactions, converting dTTP þ a-D-glucose 1-phosphate to dTDP-glucose þ PP i ). The enzyme was cloned from M. tuberculosis and transformed into an E. coli strain devoid of four dTDP-Rha biosynthetic genes. Cellular extract analysis revealed an abundance of a-D-Glc-P thymidylyltransferase activity confirming its proposed function . The product of RmlA activity is then shuttled through three sequential reactions catalyzed by dTDP-D-glucose 4,6-dehydratase (Rv3464, RmlB), dTDP-4-keto-6-deoxy-D-glucose 3,5 epimerase (Rv3465, RmlC) and dTDPRha synthase (Rv3266, RmlD) (Hoang et al. 1999; Stern et al. 1999; Ma et al. 2001 ). Both rmlB and rmlC genes have also been shown as being essential for mycobacterial growth (Li et al. 2006 ).
Galactan Precursor Synthesis
The Galf residues of the galactan domain are incorporated from the high-energy sugar nucleotide donor UDP-Galf, which is formed via two reactions. In E. coli, galactosyl residues in the pyranose ring form (UDP-Galp) are synthesized by the action of GalE, a UDP-glucose 4-epimerase, which uses UDP-glucopyranose (UDP-Glcp) as its substrate (Lemaire and Muller-Hill 1986) . A study using cell-free extracts of M. smegmatis and radiolabeled UDP-Galp showed the presence of UDP-glucose 4-epimerase activity, and the amino-terminal sequence of the isolated protein was shown to be similar to that of M. tuberculosis Rv3634 (Weston et al. 1997 ). Conversion of UDP-Galp to the furanose form occurs via ring contraction catalyzed by the flavoenzyme UDP-galactopyranose mutase (Glf ) that was first recognized in E. coli (Nassau et al. 1996) and subsequently in M. smegmatis and M. tuberculosis (Rv3809c) (Weston et al. 1997) . Allelic exchange experiments of glf in M. smegmatis highlighted the essentiality of this gene (Pan et al. 2001) .
Arabinan Precursor Synthesis
As we shall see in the following section, mycobacterial D-arabinan assembly follows a linear biosynthetic pathway that involves an assortment of membrane-bound glycosyltransferases. Although D-arabinan contains a complex mixture of glycosidic linkages, decaprenylphosphoryl-b-D-arabinofuranose (DPA) is used exclusively by all of the enzymes involved in this pathway as a lipid-linked, activated Araf substrate (Wolucka et al. 1994; Xin et al. 1997; Alderwick et al. 2005) . Synthetically derived DP[
14 C]A and an array of synthetic acceptors have determined that DPA provides Araf units in the in vitro formation of 2-linked, 3-linked, and 5-linked arabinofuranosyl linkages present in the arabinans of AG and LAM (Belanger et al. 1996; Lee et al. 1997; Xin et al. 1997 ).
Because DPA is such an indispensable molecule required for mycobacterial cell wall biosynthesis, the elucidation of the biosynthetic pathway leading to its formation has received much attention. Classical biosynthesis of such polyprenylphosphate sugars chiefly involves the donation of a glycosyl residue from an activated sugar nucleotide donor to a polyprenylphosphate substrate. Interestingly sugar nucleotides of arabinose (UDP-Ara or GDP-Ara) have not been identified in mycobacteria. Instead, the carbon skeleton of the arabinosyl residues are derived from 5-phosphoribosyl-1-pyrophosphate ( pRpp), a metabolite that emerges from the nonoxidative pentose shunt pathway (Scherman et al. 1995) . M. tuberculosis has a single pRpp synthetase, which is responsible for the formation of pRpp and uses both ribose 5-phosphate and ATP as its substrates (Alderwick et al. 2011 ). The 5-phospho-a-D-ribose-1-pyrophosphate:decaprenyl phosphate 5-phosphoribosyl transferase (Rv3806c), also annotated as UbiA, transfers the ribose-5-phosphate moiety from pRpp to decaprenylphosphate, ultimately forming decaprenylphosphoryl-5-b-D-phosphoribofuranose (DPPR) (Huang et al. 2005 (Huang et al. , 2008 . The essentiality of UbiA was highlighted in a study that used Corynebacterium glutamicum as a model organism to investigate the molecular genetics of mycobacterial D-arabinan biosynthesis. A ubiA-deficient strain of C. glutamicum resulted in a cell wall phenotype that was completely devoid of arabinose, giving incontrovertible evidence that DPA is indeed the only Araf donor for D-arabinan biosynthesis (Alderwick et al. 2005 (Alderwick et al. , 2006a . DPPR is dephosphorylated to decaprenylphosphoryl-b-D-ribofuranose (DPR) by a phosphatase enzyme encoded by Rv3807c. Genetic deletion and subsequent phenotypic studies of the M. smegmatis homolog (MSMEG6402) suggest that although this gene is not essential, its enzymatic function is required to enable cell wall biosynthesis to continue unabated (Jiang et al. 2011) . At this point, DPR is epimerized to DPA in a two-step epimerization process that involves two enzymes, DprE1 and DprE2. DprE1, encoded by rv3790, is an oxidoreductase that serves to oxidize the C-2 hydroxyl of the ribose moiety of DPR to form decaprenylphosphoryl-2-keto-b-D-erythro-pentofuranose (DPK), which is an intermediate metabolite of this essential pathway (Mikusova et al. 2005 ). DprE2, encoded by rv3791, then reduces the C2-keto of DPK, resulting in the complete synthesis of the sole Araf donor, DPA (Mikusova et al. 2005) .
At this point, it is worth giving special attention to DprE1, primarily because several recent chemical biology studies have shown that this enzyme is particularly susceptible to inhibition by a variety of small-molecule inhibitors that also show potent antimycobacterial activity. Benzothiazinones (BTZs) are a new class of sulfur-containing heterocyclic compounds that kill M. tuberculosis with nanomolar potency by targeting DprE1 (Makarov et al. 2009 ). Several biochemical and structural biology studies have shown that BTZs are suicide inhibitors, whereby BTZ is activated by DprE1, a FAD-de-pendent enzyme, forming a covalent semimercaptal bond with a key active-site cystine residue (Trefzer et al. 2010 (Trefzer et al. , 2012 Batt et al. 2012) . Subsequent high-throughput screening and highcontent screening experiments have revealed that DprE1 is an extremely "druggable" enzyme, with molecules such as the dinitrobenzamides (DNBs), nitrotriazoles, pyrazolopyridones, azaindoles, and a benzothiazoles (TCA1) (Christophe et al. 2009; Stanley et al. 2012; Shirude et al. 2013; Wang et al. 2013; Panda et al. 2014) .
Because of the apparent vulnerability of DprE1 as a key enzyme in cell wall biosynthesis, it has been lauded by many within the mycobacterial research community as a "magic drug target." Targeting D-arabinan biosynthesis ultimately results in the removal of covalent linkage between peptidoglycan and the outer mycolate layers and is a salutary approach to the development of new antimycobacterial agents. However, this is insufficient evidence to explain the vulnerable nature of DprE1 as a "magic drug target." A recent investigation into the vulnerability of DprE1 as a drug target showed that the primary consequence of DprE1 inhibition is not simply the loss of DPA formation, rather it is the accumulation of DPR in the cytoplasmic membrane that induces synthetic lethality, depleting the TB bacilli of the limited supply of decaprenylphosphate that is required for both AG and PG biosynthesis to proceed unhindered (Grover et al. 2014 ). As we shall see, a variety of membrane-bound arabinofuranosyltransferases are required to assemble D-arabinan on the periplasmic face of the cytoplasmic membrane. Because DPA is synthesized on the inner leaflet of the cytoplasmic membrane, it is necessary for DPA to be translocated to position this Araf donor in the correct orientation. Rv3789 has been identified as a DPA flippase responsible for this activity (Larrouy-Maumus et al. 2012) .
Galactan Biosynthesis
The assortment of glycosyl linkages within the galactan moiety leads to the supposition that at least two Galf transferases (GalTs) are required for its complete biosynthesis. GlfT1 (Rv3782) is classified as an inverting glycosyltransferase-2 (GT-2) of the GT-A superfamily, and it is recognized as the GalT responsible for the initial transfer of two Galf residues, using UDP-Galf as a substrate, to form both C 50 -P-P-GlcNAcRha-Galf (GL-3) and C 50 -P-P-GlcNAc-RhaGalf-Galf (GL-4) (Mikusova et al. 2006; Alderwick et al. 2008) . Using a novel neoglycolipid acceptor assay that contained isolated E. coli membranes expressing GlfT2 (Rv3808c), it was shown that this enzyme has dual functionality, acting both as a UDP-Galf :b-D-(1 ! 5) GalT and UDP-Galf:b-D-(1 ! 6) GalT, responsible for the polymerization of approximately 30 Galf residues with alternating b(1 ! 5) and b(1 ! 6) linkages (Kremer et al. 2001; Mikusova et al. 2006) . Apart from being a bifunctional GalT, GlfT2 displays additional interesting features: By using a substrate tethering mechanism, it is able to have intrinsic control of the chain length of the galactan product (May et al. 2009 ). Further structural analysis of GlfT2 using X-ray crystallography and NMR has shed further light on how this unique enzyme is tetrameric and is able to control chain length processivity and bifunctionality using a single active site (Szczepina et al. 2009; Wheatley et al. 2012 ).
Arabinan Biosynthesis
A Brief Digression on Ethambutol. As discussed earlier, D-arabinan is a pivotal scaffold structure, which serves to covalently connect PG to the outer mycolic acid layer. Its biosynthesis is also targeted by the frontline drug ethambutol (EMB). EMB is a synthetic compound that was first recognized as an antimycobacterial agent in 1961 (Thomas et al. 1961) . Early work by Kilburn and Greenberg observed an unanticipated increase in viable cells during the initial 4 h after addition of EMB to M. smegmatis cultures (Kilburn and Takayama 1981) . It was postulated that large bacillary clusters disaggregated because of a possible reduction in lipid content, which would lead to the apparent increase in colony-forming units (CFUs) (Kilburn and Takayama 1981) . This theory was supported by Takayama and coworkers who conducted a series of early studies into the effects of the EMB on M. smegmatis, reporting that inhibition of mycolic acid transfer into the cell wall and the simultaneous accumulation of trehalose-monomycolate (TMM), trehalose-dimycolate (TDM), and free mycolic acids occurred within 15 min of drug administration, suggesting that the target may be a mycolytransferase responsible for the transfer of mycolic acids onto the arabinan polymer (Takayama et al. 1979; Kilburn and Takayama 1981) . However, it was later discovered, from observing the incorporation of [ 14 C]glucose into the cell wall D-arabinose monomers, that EMB inhibits the formation of D-arabinan (Takayama and Kilburn 1989) , whereas synthesis of D-galactan of AG remained unaffected (Mikusova et al. 1995) . A major breakthrough in the discovery of the precise EMB cellular target arose through exploitation of a moderately resistant strain from the related Mycobacterium avium species. A genomic library from the aforementioned strain was screened and overexpressed in an otherwise susceptible M. smegmatis host, leading to the identification of a resistance-conferring region encompassing three complete open reading frames (ORFs), embR, embA, and embB (Belanger et al. 1996) . Moreover, use of an EMB-sensitive cell-free arabinan biosynthetic assay showed that arabinosyltransferase activity was restored with embAB overexpression. Interestingly, neither embA or embB alone was sufficient to confer multicopy resistance, thus supporting the supposition that they are translationally coupled, possibly forming a multienzyme complex (Belanger et al. 1996) . EMB resistance was also used to identify the embCAB gene cluster from M. smegmatis, which was subsequently characterized in M. tuberculosis and M. leprae, all of which possess the same syntenic organization and encode homologs of the embA and embB genes from M. avium (Lety et al. 1997; Telenti et al. 1997) . Escuyer et al. (2001) created individual genetic knockouts in M. smegmatis, embC, embA, and embB, all of which were viable, with the most profound effects observed in the embB mutant. Individual inactivation of embA and embB resulted in the diminished incorporation of arabinose into AG, specifically, the terminal dis- The Emb proteins, although novel, possess membrane topologies consistent with other glycosyltransferases (GTs) that use lipid-linked precursors, and do not resemble the more typical nucleotide-diphosphate (NDP) sugar donor requiring GTs. To date, the carbohydrate-active enzymes (CAZy) database has classified GTs into approximately 95 families with three large structural superfamilies, GT-A, GT-B, and GT-C (Liu and Mushegian 2003) . GT-A and GT-B enzymes use NDP-sugar donors and are either globular or peripheral membrane proteins. The GT-C superfamily are large integral membrane proteins, all of which contain eight to 13 predicted transmembrane (TM) domains, with typically low sequence similarity but a conserved amino acid motif, called the DxD motif, generally positioned in the first or second predicted extracytoplasmic loop, and is thought to be required for binding the polyprenylphosphosugar substrate (Berg et al. 2007 ). The Emb proteins have been classified as GT-Cs, comprising approximately 1100 amino acids and 12 -13 TM-spanning regions (Berg et al. 2005; Seidel et al. 2007b ). Efforts to generate viable embA/embB mutants in M. tuberculosis and an embAB double mutant in M. smegmatis have so far proven unfruitful, highlighting their essentiality in mycobacteria. The Corynebacterianeae taxon encompasses Mycobacterium species as well as Corynebacterium species, such as Corynebacterium diphtheriae and C. glutamicum. Corynebacterium are deemed the archetype of Corynebacterianeae, and because they maintain a low frequency of gene duplications and modifications, theyalso possess a cell wall core remarkably similar to M. tuberculosis and have served as a useful tool and model organism to study otherwise essential orthologous M. tuberculosis genes. Alderwick et al. (2005) successfully constructed a C. glutamicum mutant with its singular emb gene disrupted (Cg-emb), and subsequent phenotypic analyses of this mutant revealed an almost total loss of cell wall arabinan, except for terminal t-Araf residues decorating the galactan backbone. Moreover, EMB treatment of wild-type C. glutamicum produced a profile identical to that of the mutant, illustrating that Cg-emb is indeed the target of EMB and furthermore that another AraT responsible for "priming" the galactan backbone must exist. As described earlier, disruption of the 5-phospho-a-D-ribose-1-pyrophosphate: decaprenyl phosphate 5-phosphoribosyl transferase ortholog (Cg-ubiA), resulted in total ablation of Araf residues, indicating that the unidentified AraTwas also DPA-dependent (Alderwick et al. 2005) . This pioneering study paved the way for the discovery of several novel GT-C arabinofuransyltransferases, each of which plays key roles in D-arabinan biosynthesis. AftA was identified as the enzyme responsible for priming the 8th, 10th, and 12th Galf residues of the galactan backbone, which are elongated by the Emb proteins in an a(1 ! 5)-linked fashion (Alderwick et al. 2006b ). The M. smegmatis AftA homolog (MSMEG_6386) could only be chromosomally deleted in a merodiploid strain, highlighting its essentiality in mycobacteria (Shi et al. 2008 ). Both C. glutamicum and M. smegmatis model systems were used in combination to identify AftC as the enzyme responsible for introducing a(1 ! 3) Araf linkages into Darabinan of AG and lipoarabinomannan (LAM) (Birch et al. 2008 (Birch et al. , 2010 . Standing at 1400 amino acids in length and with a molecular mass of 150 kDa, AftD represents the largest of the GT-C AraTs present in M. tuberculosis. It has been shown that AftD shows a(1 ! 3) Araf transferase activity, but because of its disproportionally large size, is speculated to have additional functions, such as being a scaffold protein for the recruitment of additional cell wall biosynthetic enzymes (Skovierova et al. 2009 ). Again, C. glutamicum was used to identify AftB as the enzyme that transfers terminal b(1 ! 2) Araf residues into the nonreducing Ara 6 motif of AG, thus bringing AG biosynthesis to a halt (Seidel et al. 2007a ).
